Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Hormonal contraception and SSRI’s influence on oxytocin and cortisol reactivity to stress in patients with borderline personality disorder

M. Teixeira de Almeida, L. Quattrocchi, N Perroud, View ORCID ProfileT. Aboulafia-Brakha
doi: https://doi.org/10.64898/2025.12.18.25342546
M. Teixeira de Almeida
1Faculty of Medicine, University of Geneva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Quattrocchi
1Faculty of Medicine, University of Geneva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Perroud
1Faculty of Medicine, University of Geneva
2Department of Psychiatry, Geneva University Hospitals
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Aboulafia-Brakha
1Faculty of Medicine, University of Geneva
2Department of Psychiatry, Geneva University Hospitals
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T. Aboulafia-Brakha
  • For correspondence: Tatiana.aboulafia{at}hug.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Borderline personality disorder (BPD) involves emotional instability and stress sensitivity linked to oxytocinergic and HPA-axis dysregulation. This study examined oxytocin and cortisol responses to acute psychosocial stress and the modulatory effects of SSRIs and hormonal contraception.

Methods 93 female participants (45 with BPD with/without SSRIs and 48 healthy controls) underwent the Trier Social Stress Test. Linear and generalized linear mixed-effects models were applied to assess time, group, and hormonal contraception effects, and their interactions.

Results During the stress task, both BPD groups reported significantly higher subjective anxiety and anger than controls. All participants showed increased salivary oxytocin (OXT) during stress anticipation, but post-task trajectories diverged: BPD participants without SSRIs exhibited a sharp OXT decline, whereas those on SSRIs mirrored the stable trajectory of controls. Hormonal contraception reversed the OXT decline in untreated BPD participants, resulting in a progressive increase during recovery. Cortisol (CORT) analyses revealed hyporeactivity in BPD participants without SSRIs, a pattern unaffected by hormonal contraception. A significant three-way interaction indicated that higher OXT levels were associated with higher CORT concentrations during late recovery specifically in the BPD SSRI group, a relationship that was marginal in untreated patients and absent in controls.

Conclusions Our findings confirm that neuroendocrine dysregulation in BPD is context-dependent and sensitive to pharmacological modulation. The ability of SSRIs and hormonal contraception to influence stress-response patterns, despite limited efficacy on core symptoms, highlights the importance of controlling for medication and hormonal status in future BPD biomarker research.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT05357521

Funding Statement

This study was funded by the Swiss National Science Foundation. Grant number: 214932

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Geneva local ethics committe Commission Cantonale d'Ethique de la Recherche sur l'etre humain (CCER) swissethics. The basec number is the study protocol ID.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Co-authors contact information: Melanie.teixeiradealmeida{at}hug.ch, Lara.quattrocchi{at}hug.ch, Nader.Perroud{at}hug.ch

  • Local ethical committee approval: Swissethics NAC 2022-00067

  • Funding Source: Swiss national Foundation- project grant accorded to NP (32003B_214932). The funding source had no role in the conception or accomplishment of the study.

  • Credit roles: MT: investigation, data curation, formal analysis and writing-original draft; LQ: investigation, data curation, formal analysis and writing-original draft,; NP: funding acquisition, resources, supervision and writing-original draft; TAB: conceptualisation, methodology, funding acquisition, project administration, supervision, formal analysis and writing-original draft.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 20, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Hormonal contraception and SSRI’s influence on oxytocin and cortisol reactivity to stress in patients with borderline personality disorder
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hormonal contraception and SSRI’s influence on oxytocin and cortisol reactivity to stress in patients with borderline personality disorder
M. Teixeira de Almeida, L. Quattrocchi, N Perroud, T. Aboulafia-Brakha
medRxiv 2025.12.18.25342546; doi: https://doi.org/10.64898/2025.12.18.25342546
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Hormonal contraception and SSRI’s influence on oxytocin and cortisol reactivity to stress in patients with borderline personality disorder
M. Teixeira de Almeida, L. Quattrocchi, N Perroud, T. Aboulafia-Brakha
medRxiv 2025.12.18.25342546; doi: https://doi.org/10.64898/2025.12.18.25342546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (868)
  • Anesthesia (306)
  • Cardiovascular Medicine (4483)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (615)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15282)
  • Forensic Medicine (31)
  • Gastroenterology (1134)
  • Genetic and Genomic Medicine (6650)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4606)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1624)
  • Hematology (544)
  • HIV/AIDS (1276)
  • Infectious Diseases (except HIV/AIDS) (15965)
  • Intensive Care and Critical Care Medicine (1111)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (674)
  • Neurology (6698)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1153)
  • Occupational and Environmental Health (961)
  • Oncology (3370)
  • Ophthalmology (988)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (670)
  • Pediatrics (1704)
  • Pharmacology and Therapeutics (700)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5497)
  • Public and Global Health (9287)
  • Radiology and Imaging (2225)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1202)
  • Rheumatology (598)
  • Sexual and Reproductive Health (721)
  • Sports Medicine (536)
  • Surgery (722)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (267)